Glucose concentrations within target, appropriate gestational weight gain, adequate lifestyle,
and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

Diabetes in pregnancy affects 20 million women per year and is associated with increased
risk of obesity in offspring, leading to insulin resistance and cardiometabolic disease …

OBJECTIVE Continuous glucose monitoring (CGM) improves maternal glycemic control and
neonatal outcomes in type 1 diabetes pregnancies compared with self-monitoring of blood …

Background: The aim of this study was to determine the performance of the Dexcom G6
continuous glucose monitoring (CGM) system across three sensor wear sites in pregnant …

In recent years, continuous glucose monitoring (CGM) has become increasingly available
with the introduction of devices that are specifically approved for use during pregnancy …

Aims/hypothesis The aim of this study was to assess whether the addition of intermittently
scanned continuous glucose monitoring (isCGM) to standard care (self-monitoring of blood …

Despite enormous progress in managing blood glucose levels, pregnancy in women with
type 1 diabetes still carries risks for the growing fetus. While, previously, fetal undergrowth …

Aims To determine if in‐target intrapartum glucose control is associated with neonatal
hypoglycaemia in women with type 1, type 2 or gestational diabetes. Methods This was a …

Background: We evaluated accuracy and safety of a seventh-generation real-time
continuous glucose monitoring (CGM) system during pregnancy. Materials and Methods …